Aileron Therapeutics Announces Positive Data from Cohort 1 o

Aileron Therapeutics Announces Positive Data from Cohort 1 of the Phase 1b Clinical Trial of LTI-03 in Idiopathic Pulmonary Fibrosis (IPF)

Aileron Therapeutics Announces Positive Data from Cohort 1 of the Phase 1b Clinical Trial of LTI-03 in Idiopathic Pulmonary Fibrosis (IPF)

tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

United States , Germany , Pergolizzi Jr , Brian Windsor , Andreas Gunther , Head Of The Center , Exchange Commission , Company Annual Report On Form , Aileron Therapeutics Inc , Therapeutics Announces Positive Data , Clinical Trial , Idiopathic Pulmonary Fibrosis , Chief Executive Officer , Rare Lung Diseases , Justus Liebig University , Orphan Drug Designation , Fast Track Designation , What Do We Need , Know About Rising Rates , Idiopathic Pulmonary , Narrative Review , Springer Nature , Journal Volume , Aileron Therapeutics , Private Securities Litigation Reform Act , Nasdaq Stock Market , Annual Report , United States Securities , Media Contact ,